AMRN.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

Stock prediction for AMRN.US - Amarin Corporation PLC

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin 2, Ireland.

symbol	last	change	%chng	name	mcap	sector	wiki
AMRN				Amarin Corporation PLC	0.189B	Healthcare	wiki y

	symbol	prev.close	range	chart	target	percent	period	months	due	rating
C	AMRN	10.43	0,-0.997,0.376,0.610,-0.997	11.18,11.89,11.63,11.15,11.30,11.91,11.27,10.45,8.64,8.80,9.16,8.59,8.85,9.44,10.39	7.73-10.92	-10.60%	267,111,267	5.2	Jan 6-Sep 30	47.79%

stock prediction graph

prediction values

stock	low target	target	high target	to go	days	target date
AMRN	7.73	9.32	10.92	-11.40%	267	Sep 30
AMRN	8.16	9.37	10.58	-10.94%	177	Jul 2
AMRN	8.24	9.39	10.54	-10.70%	167	Jun 22
AMRN	8.27	9.37	10.47	-10.92%	157	Jun 12
AMRN	8.35	9.39	10.43	-10.74%	147	Jun 2
AMRN	8.44	9.45	10.46	-10.12%	137	May 23
AMRN	8.53	9.46	10.40	-9.95%	127	May 13
AMRN	8.55	9.43	10.31	-10.28%	117	May 3
AMRN	8.64	9.47	10.29	-9.90%	107	Apr 23
AMRN	8.65	9.42	10.19	-10.36%	97	Apr 13

``` ```